BMO Capital Maintains Outperform on Corteva, Lowers Price Target to $95
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice TargetHot
BMO Capital analyst Joel Jackson maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $100 to $95.
BMO Capital analyst Joel Jackson maintains Corteva (NYSE:CTVA) with a Outperform and lowers the price target from $100 to $95.